Text Size: A / A
Print Email

FDA-Approved Drugs

Gemzar (gemcitabine hcl)

FDA Approved July 2006

This drug is approved for treatment of patients with ovarian cancer. Gemcitabine can interfere with the growth of rapidly growing cells, like cancer cells, and eventually causes cell death. Gemcitabine is used alone or in combination with other chemotherapy agents.

Doxil (doxorubicin liposomal)

FDA Approved January 2005

This drug is approved for treatment of patients with ovarian cancer whose disease has progressed or recurred after both paclitaxel- and  platinum-based chemotherapy.

Taxol (paclitaxel)

FDA Approved June 2000

Paclitaxel is made from the needles and bark of certain kinds of yew trees. Paclitaxel interferes with the growth of rapidly dividing cells, like cancer cells, and eventually causes these cells to die. Paclitaxel may be used alone or with other chemotherapy agents or radiation therapy. Generic paclitaxel injections are available.

 

Online Medical Reviewer: Pierce-Smith, Daphne RN, MSN, CCRC, FNP
Online Medical Reviewer: Stump-Sutliff, Kim RN, MSN, AOCNS
Last Review Date: 8/26/2009
© 2013 Krames StayWell, 780 Township Line Road, Yardley, PA 19067. All rights reserved. This information is not intended as a substitute for professional medical care. Always follow your healthcare provider's instructions.

Blue Cross Blue Shield of Massachusetts is an Independent Licensee of the Blue Cross and Blue Shield Association.
® Registered Marks of the Blue Cross and Blue Shield Association.
SM Service Marks of the Blue Cross and Blue Shield of Massachusetts.

About This Site | Feedback

Powered By Krames StayWell
Copyright © Krames StayWell except where otherwise noted.
View Mobile Site